{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:13:06Z","timestamp":1708474386596},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>To characterize the susceptibilities of positive bacterial cultures and the appropriateness of empiric antimicrobial regimens for patients admitted from post\u2013acute care facilities (PACFs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a retrospective quality improvement study. The study included patients admitted from a PACF to one of 2 tertiary care teaching hospitals within the University of Pennsylvania Health System, located in Philadelphia, PA, from August 2020 to December 2021. Patients were included if they had at least one positive culture within 72 hours of admission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 167 patients and 230 isolates from the study period were evaluated. The majority of positive cultures were from a urinary source (114 of 230, 49.6%). Nineteen patients (11.4%) had a history of multidrug-resistant organisms. The most common empiric antibiotics used were vancomycin (61.7%) and cefepime (59.3%). Sixty-one patients (36.5%) received inappropriate empiric therapy based on the culture results. When comparing our hospitals\u2019 general antibiogram to that of only PACF patients, Escherichia coli and Klebsiella pneumoniae had at least a 20% difference in susceptibility to levofloxacin, ceftriaxone, and cefepime. Extended-spectrum \u03b2-lactamase resistance was also higher in the PACF cohort (odds ratio, 2.09; 95% confidence interval, 1.4-3.1).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Clinically significant differences in antimicrobial susceptibility were found among patients admitted from PACFs compared to our health system\u2019s general antibiogram. The increased resistance rates identified in this study support the need for hospitals to evaluate this at-risk patient population, which may drive changes to empiric antibiotic prescribing practices.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxad290","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T17:02:46Z","timestamp":1700326966000},"page":"S8-S14","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance patterns and empiric antibiotic selections for patients admitted from post\u2013acute care facilities"],"prefix":"10.1093","volume":"81","author":[{"given":"Sandhya","family":"Vijapurapu","sequence":"first","affiliation":[{"name":"Penn Presbyterian Medical Center , Philadelphia, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Maguire","sequence":"additional","affiliation":[{"name":"Penn Presbyterian Medical Center , Philadelphia, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Binkley","sequence":"additional","affiliation":[{"name":"Penn Presbyterian Medical Center , Philadelphia, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Binkley","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Lamore","sequence":"additional","affiliation":[{"name":"Penn Presbyterian Medical Center , Philadelphia, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"issue":"3","key":"2024022012180421200_CIT0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"6","key":"2024022012180421200_CIT0002","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"2024022012180421200_CIT0003","first-page":"1589","article-title":"Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms","volume":"34","author":"Klinker","year":"2021","journal-title":"Ther Adv Infect Dis"},{"issue":"2","key":"2024022012180421200_CIT0004","doi-asserted-by":"crossref","first-page":"dlab060","DOI":"10.1093\/jacamr\/dlab060","article-title":"The antibiogram: key considerations for its development and utilization","volume":"3","author":"Truong","year":"2021","journal-title":"JAC Antimicrob Resist"},{"issue":"3","key":"2024022012180421200_CIT0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/dky488","article-title":"Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study","volume":"74","author":"Pulcini","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"2024022012180421200_CIT0006","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1017\/ice.2019.108","article-title":"Antimicrobial resistance patterns of urine culture specimens from 27 nursing homes: impact of a two-year antimicrobial stewardship intervention","volume":"40","author":"Tandan","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"2024022012180421200_CIT0007","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3349\/ymj.2017.58.1.180","article-title":"Antimicrobial resistance and clinical outcomes in nursing home-acquired pneumonia, compared to community-acquired pneumonia","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med J"},{"issue":"1","key":"2024022012180421200_CIT0008","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jamda.2019.07.016","article-title":"Antibiograms cannot be used interchangeably between acute care medical centers and affiliated nursing homes","volume":"21","author":"Hughes","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"2024022012180421200_CIT0009","doi-asserted-by":"crossref","first-page":"e2144959","DOI":"10.1001\/jamanetworkopen.2021.44959","article-title":"Association of exposure to high-risk antibiotics in acute care hospitals with multidrug-resistant organism burden in nursing homes","volume":"5","author":"Gontjes","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2024022012180421200_CIT0010","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2024022012180421200_CIT0011","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/511864","article-title":"Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute","volume":"44","author":"Hindler","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2024022012180421200_CIT0012","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2024022012180421200_CIT0013","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/ice.2019.112","article-title":"Creating reasonable antibiograms for antibiotic stewardship programs in nursing homes: analysis of 260 facilities in a large geographic region, 2016-2017","volume":"40","author":"Fridkin","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"2024022012180421200_CIT0014","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jamda.2018.05.006","article-title":"Antimicrobial stewardship in long-term care facilities: approaches to creating an antibiogram when few bacterial isolates are cultured annually","volume":"19","author":"Tolg","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"2024022012180421200_CIT0015","volume-title":"Infectious Diseases Society of America Antimicrobial-Resistant Treatment Guidance: Gram-Negative Bacterial Infections","author":"Tamma","year":"2022"},{"key":"2024022012180421200_CIT0016","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab1013","volume-title":"Infectious Diseases Society of America Guidance on the Treatment of AmpC\n            \u03b2-\n            Lactamase-Producing Enterobacterales, Carbapenem-Resistant\n            Acinetobacter baumannii,\n            and St\n            enotrophomonas maltophilia\n            Infections.","author":"Tamma","year":"2022"},{"key":"2024022012180421200_CIT0017","article-title":"Performance Standards for Antimicrobial Susceptibility Testing","volume-title":"CLSI standard M100","author":"Clinical and Laboratory Standards Institute","year":"2020","edition":"32"},{"key":"2024022012180421200_CIT0018","volume-title":"Breakpoints tables for interpretations of MICs and zone diameters, version 12.0","author":"European"},{"key":"2024022012180421200_CIT0019","volume-title":"Antimicrobial Use and Resistance Module","author":"National Healthcare Safety Network","year":"2022"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxad290\/54182830\/zxad290.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/81\/Supplement_1\/S8\/56689631\/zxad290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/81\/Supplement_1\/S8\/56689631\/zxad290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T12:18:38Z","timestamp":1708431518000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/81\/Supplement_1\/S8\/7428846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":19,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2023,11,18]]},"published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxad290","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,11,18]]}}}